{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:04:28Z","timestamp":1790989468354,"version":"4.1.0"},"reference-count":91,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:p>Parvovirus B19 virus infection is widespread among humans because of its highly infectious and obstinate nature, with up to 80% of the population testing positive for IgG antibodies against the virus. Pronormoblasts observed in biopsy are the hallmarks of PVB19 infection. In addition, PVB19 affects the skin, heart, brain, joints, and liver and can be diagnosed through antibody detection or DNA detection via PCR. Due to its capsid proteins\u2019 high affinity for bone marrow receptors, its main presentation is the suppression of bone marrow functions. It has been shown to affect patients with hemolytic anemia and patients with hematological malignancies, presenting with pure red cell aplasia. The main available effective treatment option is IV immunoglobulins; however, the risk of recurrence remains high after treatment.<\/jats:p>","DOI":"10.56875\/2589-0646.1031","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T11:30:20Z","timestamp":1686655820000},"page":"316-322","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Hematologic Manifestations of Parvovirus B19 Infection"],"prefix":"10.4103","volume":"16","author":[{"given":"Ghada","family":"Algwaiz","sequence":"first","affiliation":[{"name":"Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abrar","family":"Alharbi","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khuloud","family":"Alsehaim","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alahmari","sequence":"additional","affiliation":[{"name":"Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"El Fakih","sequence":"additional","affiliation":[{"name":"Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Aljurf","sequence":"additional","affiliation":[{"name":"Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5,23]]},"reference":[{"key":"R1-20241211","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(75)91074-0","article-title":"Parvovirus-like particles in human sera","volume":"1","author":"Cossart","year":"1975","journal-title":"Lancet"},{"key":"R2-20241211","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0140-6736(93)91145-C","article-title":"Human parvovirus infection in homozygous sickle cell disease","volume":"341","author":"Serjeant","year":"1993","journal-title":"Lancet"},{"key":"R3-20241211","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1590\/S0074-02762009000600013","article-title":"Relationship among epidemiological parameters of six childhood infections in a non-immunized Brazilian community","volume":"104","author":"Amaku","year":"2009","journal-title":"Mem I Oswaldo Cruz"},{"key":"R4-20241211","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0140-6736(95)90850-1","article-title":"Persistent parvovirus infection","volume":"345","author":"Kerr","year":"1995","journal-title":"Lancet"},{"key":"R5-20241211","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.siny.2009.01.007","article-title":"Parvovirus B19 infection","volume":"14","author":"Tolfvenstam","year":"2009","journal-title":"Semin Fetal Neonatal Med"},{"key":"R6-20241211","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1182\/blood-2005-03-1053","article-title":"Persistent B19 infection in immunocompetent individuals: implications for transfusion safety","volume":"106","author":"Lefrere","year":"2005","journal-title":"Blood"},{"key":"R7-20241211","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2249.2005.02886.x","article-title":"T-helper cell mediated interferon-gamma expression after human parvovirus B19 infection: persistent VP2 specific and transient VPu-specific activity","volume":"142","author":"Franssila","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"R8-20241211","article-title":"International Committee on","journal-title":"Taxonomy of viruses (ICTV) virus taxonomy"},{"key":"R9-20241211","doi-asserted-by":"crossref","first-page":"11784","DOI":"10.1128\/JVI.01399-08","article-title":"Interaction of Parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity","volume":"82","author":"Bonsch","year":"2008","journal-title":"J Virol"},{"key":"R10-20241211","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1128\/JVI.02430-05","article-title":"Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity","volume":"80","author":"Zhi","year":"2006","journal-title":"J Virol"},{"key":"R11-20241211","doi-asserted-by":"crossref","first-page":"7555","DOI":"10.1128\/JVI.75.16.7555-7563.2001","article-title":"Human parvovirus B19 induces cell cycle arrest at G2 phase with accumulation of mitotic cyclins","volume":"75","author":"Morita","year":"2001","journal-title":"J Virol"},{"key":"R12-20241211","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/stem.140151","article-title":"Parvoviruses and bone marrow failure","volume":"14","author":"Brown","year":"1996","journal-title":"Stem Cell"},{"key":"R13-20241211","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1089\/hum.2006.17.909","article-title":"Role of integrin cross-regulation in parvovirus B19 targeting","volume":"17","author":"Weigel-Kelley Kirsten","year":"2006","journal-title":"Hum Gene Ther"},{"key":"R14-20241211","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1172\/JCI41805","article-title":"Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors","volume":"120","author":"Wan","year":"2010","journal-title":"J Clin Invest"},{"key":"R15-20241211","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0163-4453(97)92928-5","article-title":"Parvovirus B19 infection in Hong Kong","volume":"35","author":"Lim","year":"1997","journal-title":"J Infect"},{"key":"R16-20241211","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/CMR.15.3.485-505.2002","article-title":"Human parvovirus B19","volume":"15","author":"Heegaard","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"R17-20241211","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMra030840","article-title":"Parvovirus B19","volume":"350","author":"Young","year":"2004","journal-title":"N Engl J Med."},{"issue":"5130","key":"R18-20241211","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1126\/science.8211117","article-title":"Erythrocyte P antigen: cellular receptor for B19 parvovirus","volume":"262","author":"Brown","year":"1993","journal-title":"Science"},{"issue":"3","key":"R19-20241211","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/JCM.40.3.933-936.2002","article-title":"Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals","volume":"40","author":"Heegaard","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"4","key":"R20-20241211","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/hp.2000.6714","article-title":"The cutaneous manifestations of human parvovirus B19 infection","volume":"31","author":"Magro","year":"2000","journal-title":"Hum Pathol"},{"issue":"3","key":"R21-20241211","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/pin.12643","article-title":"Post-infectious acute glomerulonephritis with podo- cytopathy induced by parvovirus B19 infection","volume":"68","author":"Hara","year":"2018","journal-title":"Pathol Int"},{"key":"R22-20241211","first-page":"4720","article-title":"Parvovirus b19 associated hepatitis","volume":"2013","author":"Bihari","year":"2013","journal-title":"Hepat Res Treat"},{"key":"R23-20241211","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1128\/JCM.00575-11","article-title":"Acute hepatitis as a manifestation of parvovirus B19 infection","volume":"49","author":"Hatakka","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R24-20241211","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0046-8177(00)80215-4","article-title":"Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients","volume":"31","author":"Crook","year":"2000","journal-title":"Hum Pathol"},{"issue":"1","key":"R25-20241211","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12288-013-0287-7","article-title":"Acute human parvovirus b19 infection: cytologic diagnosis","volume":"30","author":"Sharada Raju","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R26-20241211","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/blood.V3.3.231.231","article-title":"Congenital hemolytic jaundice. The pathogenesis of the \"hemolytic crisis","volume":"3","author":"Owren","year":"1948","journal-title":"Blood"},{"key":"R27-20241211","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/adc.87.6.541","article-title":"Acute encephalopathy with parvovirus B19 infection in sickle cell disease","volume":"87","author":"Bakhshi","year":"2002","journal-title":"Arch Dis Child"},{"key":"R28-20241211","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJM198908243210807","article-title":"Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy (Comments)","volume":"321","author":"Kurtzman","year":"1989","journal-title":"N Engl J Med"},{"key":"R29-20241211","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7883\/yoken.JJID.2005.149","article-title":"Spontaneous resolution of hemophagocytic syndrome and disseminated intravascular coagulation associated with parvovirus b19 infection in a previously healthy child","volume":"58","author":"Kaya","year":"2005","journal-title":"Jpn J Infect Dis"},{"key":"R30-20241211","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0046-8177(97)90146-5","article-title":"Human parvovirus B19 in bone marrows from adults with acquired immunodeficiency syndrome: a comparative study using in situ hybridization and immunohistochemistry","volume":"28","author":"Liu","year":"1997","journal-title":"Hum Pathol"},{"key":"R31-20241211","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2141.1991.tb04425.x","article-title":"Congenital spherocytosis, B19 parvovirus infection and inherited interstitial deletion of the short arm of chromosome 8","volume":"178","author":"Cohen","year":"1991","journal-title":"Br J Haematol"},{"key":"R32-20241211","first-page":"178","article-title":"Morphological diagnosis of parvovirus B19 infection: a cytopathic effect easily recognized in air-dried, formalin-fixed bone marrow smears stained with hematoxylin-eosin or Wright-Giemsa","volume":"16","author":"Krause","year":"1992","journal-title":"Arch Pathol Lab Med I"},{"key":"R33-20241211","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/jcm.31.2.323-328.1993","article-title":"Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction","volume":"31","author":"McOmish","year":"1993","journal-title":"J Clin Microbiol"},{"key":"R34-20241211","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/jcm.31.3.540-546.1993","article-title":"Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19","volume":"31","author":"Patou","year":"1993","journal-title":"J Clin Microbiol"},{"key":"R35-20241211","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1128\/jcm.24.4.522-526.1986","article-title":"Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay","volume":"24","author":"Anderson","year":"1986","journal-title":"J Clin Microbiol"},{"key":"R36-20241211","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2141.1995.tb05427.x","article-title":"Incidence of human parvovirus B19 DNA detection in blood donors","volume":"91","author":"Yoto","year":"1995","journal-title":"Br J Haematol"},{"key":"R37-20241211","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0268-960X(87)90020-8","article-title":"B19 virus\u2013a pathogenic human parvovirus","volume":"1","author":"Pattison","year":"1987","journal-title":"Blood Rev"},{"key":"R38-20241211","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4103\/ijmr.IJMR_533_18","article-title":"Clinical impact & pathogenic mechanisms of human parvovirus B19: a multiorgan disease inflictor incognito","volume":"148","author":"Kishore","year":"2018","journal-title":"Indian J Med Res"},{"key":"R39-20241211","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/0973-6247.83239","article-title":"Serological study on parvovirus B19 infection in multitransfused thalassemia major patients and its transmission through donor units","volume":"5","author":"Kishore","year":"2011","journal-title":"Asian J Transfus Sci"},{"key":"R40-20241211","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1111\/j.1537-2995.2005.00610.x","article-title":"Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products","volume":"45","author":"Plentz","year":"2005","journal-title":"Transfusion"},{"key":"R41-20241211","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1537-2995.2005.04267.x","article-title":"Autologous peripheral blood progenitor cells are a potential source of parvovirus B19 infection","volume":"45","author":"Arnold","year":"2005","journal-title":"Transfusion"},{"key":"R42-20241211","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1537-2995.2005.04387.x","article-title":"Parvovirus B19 transmission by a high-purity factor VIII concentrate","volume":"45","author":"Wu","year":"2005","journal-title":"Transfusion"},{"key":"R43-20241211","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1537-2995.2012.03907.x","article-title":"Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening","volume":"53","author":"Soucie","year":"2013","journal-title":"Transfusion"},{"key":"R44-20241211","first-page":"214","article-title":"The prevalence of parvovirus B19 infection among pregnant women of Ardabil in 2013","volume":"8","author":"Habibzadeh","year":"2016","journal-title":"Iran J Microbiol"},{"key":"R45-20241211","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1365-2141.2000.02429.x","article-title":"Pure red cell aplasia","volume":"111","author":"Fisch","year":"2000","journal-title":"Br J Haematol"},{"key":"R46-20241211","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/(SICI)1096-9071(199811)56:3<192::AID-JMV3>3.0.CO;2-2","article-title":"Development of antibodies to the nonstructural protein NS1 of parvovirus B19 during acute symptomatic and subclinical infection in pregnancy: implications for pathogenesis doubtful","volume":"56","author":"Searle","year":"1998","journal-title":"J Med Virol"},{"key":"R47-20241211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-7-137","article-title":"Human parvovirus B19-induced aplastic crisis in an adult patient with hereditary spherocytosis: a case report and review of the literature","volume":"7","author":"Kobayashi","year":"2014","journal-title":"BMC Res Notes"},{"key":"R48-20241211","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7326\/0003-4819-113-12-926","article-title":"Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS","volume":"113","author":"Frickhofen","year":"1990","journal-title":"Ann Intern Med"},{"key":"R49-20241211","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1365-2141.1994.tb06743.x","article-title":"Parvovirus B19 as a cause of acquired chronic pure red cell aplasia","volume":"87","author":"Frickhofen","year":"1994","journal-title":"Br J Haematol"},{"key":"R50-20241211","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJM198908243210807","article-title":"Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy","volume":"321","author":"Kurtzman","year":"1989","journal-title":"N Engl J Med"},{"key":"R52-20241211","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/infdis\/152.2.257","article-title":"Experimental parvoviral infection in humans","volume":"152","author":"Anderson","year":"1985","journal-title":"J Infect Dis"},{"key":"R53-20241211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/1040-8428(94)90040-X","article-title":"Molecular, cellular and clinical aspects of parvovirus B19 infection","volume":"16","author":"Brown","year":"1994","journal-title":"Crit Rev Oncol Hematol"},{"key":"R54-20241211","first-page":"485","article-title":"Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro","volume":"15","author":"Ozawa","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"R55-20241211","first-page":"2757450","article-title":"A meta-analysis on the seroprevalence of parvovirus B19 among patients with sickle cell disease","volume":"2019","author":"Obeid Mohamed","year":"2019","journal-title":"Bio- Med Res Int"},{"key":"R56-20241211","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(81)91579-8","article-title":"Parvovirus infections and hypoplastic crisis in sickle-cell anemia","volume":"1","author":"Pattison","year":"1981","journal-title":"Lancet"},{"key":"R57-20241211","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/1535370216636723","article-title":"Parvovirus B19 infection in children with sickle cell disease in the hydroxyurea era","volume":"241","author":"Hankins","year":"2016","journal-title":"Exp Biol Med"},{"key":"R58-20241211","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1067\/mpd.2001.117070","article-title":"Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease","volume":"13","author":"Wierenga","year":"2001","journal-title":"J Pediatr"},{"key":"R59-20241211","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/003655499750006128","article-title":"Prevalence of parvovirus B19 DNA in bone marrow of patients with haematological disorders","volume":"31","author":"Lundqvist","year":"1999","journal-title":"Scand J Infect Dis"},{"key":"R60-20241211","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jmv.10517","article-title":"Parvovirus B19 infection in Taiwanese patients with hematological disorders","volume":"71","author":"Lee","year":"2003","journal-title":"J Med Virol"},{"key":"R61-20241211","doi-asserted-by":"crossref","first-page":"9008","DOI":"10.1128\/jvi.71.12.9008-9015.1997","article-title":"Directed integration of minute virus of mice DNA into episomes","volume":"71","author":"Corsini","year":"1997","journal-title":"J Virol"},{"key":"R62-20241211","first-page":"501","article-title":"Infections with DNA viruses, adenovirus, polyomaviruses, and parvovirus B19 in hematopoietic stem cell transplant recipients and patients with hematologic malignancies","volume":"33","author":"Obeid","year":"2019","journal-title":"Infect Dis Clin"},{"key":"R63-20241211","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.bmt.1704993","article-title":"Reduced intensity conditioning bone marrow transplantation for pure red cell aplasia: successful outcome but difficult post transplant course","volume":"36","author":"Kochethu","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R64-20241211","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/JVI.73.3.1974-1979.1999","article-title":"Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins","volume":"73","author":"Gigler","year":"1999","journal-title":"J Virol"},{"key":"R65-20241211","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.meegid.2017.11.021","article-title":"Incidence and progression of Parvovirus B19 infection and molecular changes in circulating B19V strains in children with haematological malignancy: a follow up study","volume":"57","author":"Jain","year":"2018","journal-title":"Infect Genet Evol"},{"key":"R66-20241211","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/526522","article-title":"Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy","volume":"46","author":"Lindblom","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R67-20241211","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1086\/652286","article-title":"Evaluation of parvovirus B19 infection in children with malignant or hematological disorders","volume":"50","author":"Gustafsson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R68-20241211","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1099\/00222615-25-2-151","article-title":"The prevalence of antibody to human parvovirus B19 in England and Wales","volume":"25","author":"Cohen","year":"1988","journal-title":"J Med Microbiol"},{"key":"R69-20241211","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1423-0410.1995.tb02595.x","article-title":"Human parvovirus B19 infection in blood donors","volume":"69","author":"Tsujimura","year":"1995","journal-title":"Vox Sang"},{"key":"R70-20241211","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/jhin.2000.0771","article-title":"Outbreak of human parvovirus B19 in hospital workers","volume":"45","author":"Miyamoto","year":"2000","journal-title":"J Hosp Infect"},{"key":"R71-20241211","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.leu.2400527","article-title":"Pure red cell aplasia caused by B19 parvovirus infection after autologous blood stem cell transplantation in a patient with chronic lymphocytic leukemia","volume":"11","author":"It\u00e4l\u00e4","year":"1997","journal-title":"Leukemia"},{"key":"R72-20241211","doi-asserted-by":"crossref","first-page":"E239","DOI":"10.1111\/tid.12155","article-title":"Persistent parvovirus B19 infection resulting in red cell aplasia after allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Koda","year":"2013","journal-title":"Transpl Infect Dis"},{"key":"R73-20241211","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1399-3062.2007.00266.x","article-title":"Pure red cell aplasia due to parvovirus B19 infection transmitted probably through hematopoietic stem cell transplantation","volume":"10","author":"Wasak-Szulkowska","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"R74-20241211","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jmii.2019.05.009","article-title":"Human parvovirus B19 infection in patients with or without underlying diseases","volume":"52","author":"Sim","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"R75-20241211","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00006454-199103000-00018","article-title":"Parvovirus B- 19 infection: aplastic crisis, erythema infectiosum and idiopathic thrombocytopenic purpura","volume":"10","author":"Inoue","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"R76-20241211","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2141.1992.tb06416.x","article-title":"Transient erythroblastopenia of childhood with megakaryocytopenia associated with human parvovirus B19 infection","volume":"80","author":"Nagai","year":"1992","journal-title":"Br J Haematol"},{"key":"R77-20241211","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1128\/jvi.62.8.2884-2889.1988","article-title":"The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells","volume":"62","author":"Ozawa","year":"1998","journal-title":"J Virol"},{"key":"R78-20241211","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1182\/blood.V76.10.1997.1997","article-title":"Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro","volume":"76","author":"Srivastava","year":"1990","journal-title":"Blood"},{"key":"R79-20241211","first-page":"638","article-title":"Human parvovirus infection","volume":"14","author":"Nesher","year":"1997","journal-title":"Infect Med"},{"key":"R80-20241211","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/00006454-199411000-00022","article-title":"Parvovirus B19 infection in a hypogammaglobulinemic infant with neurologic disorders and anemia: successful immunoglobulin therapy","volume":"13","author":"Nigro","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"R81-20241211","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/adc.68.6.784","article-title":"Aseptic meningitis caused by human parvovirus B19","volume":"68","author":"Okumura","year":"1993","journal-title":"Arch Dis Child"},{"key":"R82-20241211","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00006454-199904000-00024","article-title":"Chronic parvovirus B19 meningitis in a child with acute lymphocytic leukemia","volume":"18","author":"Sinclair","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"R83-20241211","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(05)60609-5","article-title":"Parvovirus B19 and acute hepatitis in adults","volume":"351","author":"Hillingso","year":"1998","journal-title":"Lancet"},{"key":"R84-20241211","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1053\/hupa.2001.22743","article-title":"Fatal parvovirus myocarditis in a 5-year-old girl","volume":"32","author":"Murry","year":"2001","journal-title":"Hum Pathol"},{"key":"R85-20241211","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2007-994201","article-title":"An association between fetal parvovirus B19 infection and fetal anomalies: a report of two cases","volume":"13","author":"Katz","year":"1998","journal-title":"Am J Perinatol"},{"key":"R86-20241211","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1471-0528.1996.tb09664.x","article-title":"Fetal pathology in intrauterine death due to parvovirus B19 infection","volume":"103","author":"Wright","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"R87-20241211","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0029-7844(97)00701-1","article-title":"Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms","volume":"91","author":"Harger","year":"1998","journal-title":"Obstet Gynecol"},{"issue":"2","key":"R88-20241211","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00277-011-1238-8","article-title":"Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma","volume":"91","author":"Yang","year":"2011","journal-title":"Ann Hematol"},{"issue":"12","key":"R89-20241211","first-page":"49","article-title":"Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine\/ cyclophosphamide and rituximab for relapsed B cell lymphoma","volume":"91","author":"Hartmann","year":"2006","journal-title":"Haematologica"},{"key":"R90-20241211","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejim.2006.05.002","article-title":"Parvovirus B19 reactivation presenting as neutropenia after rituximab treatment","volume":"17","author":"Klepfish","year":"2006","journal-title":"Eur J Intern Med"},{"key":"R91-20241211","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.2147\/IDR.S321936","article-title":"Foscarnet therapy for pure red cell aplasia related to human parvovirus B19 infection in kidney transplant recipients: a preliminary exploration","volume":"14","author":"Yu","year":"2021","journal-title":"Infect Drug Resist"},{"key":"R92-20241211","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.annonc.2021.12.003","article-title":"Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European society for blood and marrow transplantation (EBMT) and the joint accreditation committee of ISCT and EBMT (JACIE) and the European haematology association (EHA)","volume":"33","author":"Hayden","year":"2022","journal-title":"Ann Oncol"}],"container-title":["Hematology\/Oncology and Stem Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.56875\/2589-0646.1031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:34:01Z","timestamp":1787067241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.56875\/2589-0646.1031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,23]]},"references-count":91,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.56875\/2589-0646.1031","relation":{},"ISSN":["1658-3876","2589-0646"],"issn-type":[{"value":"1658-3876","type":"print"},{"value":"2589-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,23]]},"assertion":[{"value":"2022-04-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}